Previous Close | 1.9500 |
Open | 0.7500 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 360.00 |
Expire Date | 2024-05-17 |
Day's Range | 0.7500 - 1.9500 |
Contract Range | N/A |
Volume | |
Open Interest | 78 |
Elevated facility operating costs and lower interest income strain Brookdale's (BKD) Q1 results, which were partly offset by favorable occupancy rates fetching improved resident fees.
Pediatrix's (MD) Q1 results benefit from higher same-unit revenues, resulting from growing patient volumes, partly offset by high costs. It continues to expect 2024 adjusted EBITDA within $200-$220 million.
Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.